Longer Overall Survival in A Patient with Advanced Non-small Cell Lung Cancer Treated with Chinese Medicine and Chemotherapy

Non-small cell lung cancer （NSCLC） is the leading cause of cancer death in the industrialized world. Despite significant progress in early stage of the disease, the overall survival rates for advanced disease remain low. Herein we present a case of NSCLC who was treated with Chinese medicine and che...

Full description

Saved in:
Bibliographic Details
Published in:Chinese journal of integrative medicine 2012-08, Vol.18 (8), p.626-628
Main Author: 陈衍智 李占东 周宁 孙红 李萍萍
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Carcinoma, Non-Small-Cell Lung - diagnostic imaging
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - pathology
Case Report
Drugs, Chinese Herbal - therapeutic use
Female
Humans
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - drug therapy
Lung Neoplasms - pathology
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Staging
Survival Analysis
Taxoids - therapeutic use
Tomography, X-Ray Computed
中国医药
化疗
患者
早期阶段
晚期
治疗
生存期
非小细胞肺癌
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-small cell lung cancer （NSCLC） is the leading cause of cancer death in the industrialized world. Despite significant progress in early stage of the disease, the overall survival rates for advanced disease remain low. Herein we present a case of NSCLC who was treated with Chinese medicine and chemotherapy with a longer overall survival.
ISSN:1672-0415
1993-0402
DOI:10.1007/s11655-012-1171-2